BioCentury | Jun 16, 2014
Company News

B. Braun Melsungen, CeGaT deal

...to disclose the ownership ratio of the JV or the profit split on diagnostic sales. B. Braun Melsungen AG...
BioCentury | Dec 13, 2010
Company News

Abbott, B. Braun Melsungen AG, Boehringer Ingelheim pharmaceuticals news

...paid $14.7 million to resolve allegations involving 49 products. Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. B. Braun Melsungen AG...
BioCentury | Dec 8, 2010
Company News

Three companies settle false claims allegations

...Boehringer Ingelheim GmbH (Ingelheim, Germany) paid $280 million, Abbott Laboratories (NYSE:ABT) paid $126.5 million and B. Braun Melsungen AG...
BioCentury | Aug 25, 2003
Company News

Advanced Medical Solutions, B. Braun Melsungen AG sales and marketing update

...the wound healing product under its Askina Sorb brand. Advanced Medical Solutions (LSE:AMS), Winsford, U.K. B. Braun Melsungen AG...
BioCentury | Oct 6, 1997
Company News

Genzyme Transgenics, B. Braun Melsungen AG deal

...while GZTC retains certain marketing rights in North America. Genzyme Transgenics Corp. (GZTC), Framingham, Mass. B. Braun Melsungen AG...
Items per page:
1 - 5 of 5
BioCentury | Jun 16, 2014
Company News

B. Braun Melsungen, CeGaT deal

...to disclose the ownership ratio of the JV or the profit split on diagnostic sales. B. Braun Melsungen AG...
BioCentury | Dec 13, 2010
Company News

Abbott, B. Braun Melsungen AG, Boehringer Ingelheim pharmaceuticals news

...paid $14.7 million to resolve allegations involving 49 products. Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. B. Braun Melsungen AG...
BioCentury | Dec 8, 2010
Company News

Three companies settle false claims allegations

...Boehringer Ingelheim GmbH (Ingelheim, Germany) paid $280 million, Abbott Laboratories (NYSE:ABT) paid $126.5 million and B. Braun Melsungen AG...
BioCentury | Aug 25, 2003
Company News

Advanced Medical Solutions, B. Braun Melsungen AG sales and marketing update

...the wound healing product under its Askina Sorb brand. Advanced Medical Solutions (LSE:AMS), Winsford, U.K. B. Braun Melsungen AG...
BioCentury | Oct 6, 1997
Company News

Genzyme Transgenics, B. Braun Melsungen AG deal

...while GZTC retains certain marketing rights in North America. Genzyme Transgenics Corp. (GZTC), Framingham, Mass. B. Braun Melsungen AG...
Items per page:
1 - 5 of 5